Drug intelligence / Profile preview

VI Peel + botulinum toxin type A

Development stage
Unknown
Lead developer
VI Peel
Modality
Recombinant Proteins and Enzymes, Small Molecules
Administration
Topical (vi Peel), Intramuscular (botulinum Toxin Type A, For Cosmetic Injections)
01

Overview

A combination cosmetic procedure involving **VI Peel**, a medium-depth chemical peel containing a proprietary blend of **trichloroacetic acid (TCA), phenol, salicylic acid, retinoic acid/tretinoin, and vitamin C**, and **botulinum toxin type A**, a neurotoxin that blocks acetylcholine release at neuromuscular junctions, resulting in temporary muscle paralysis. VI Peel induces controlled skin exfoliation and stimulates collagen, improving pigment, texture, and fine lines, while botulinum toxin type A prevents muscle contraction, reducing dynamic and static wrinkles. The combined approach targets multiple skin aging mechanisms and has been shown to be a safe and effective treatment for improving wrinkles, pigmentation, and overall skin tone with improved patient satisfaction over monotherapies[1][3][5].

Brand names
VI Peel + botulinum toxin type AToxBooster
Other names
VI Peel and BotoxVI Peel and botulinum toxin type AChemical peel and Botox combinationToxBooster
02

Targets

SV2B (Synaptic vesicle glycoprotein 2B)SNAP25 (Synaptosome-associated protein 25)

Beyond the preview

Go deeper on VI Peel + botulinum toxin type A.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VI Peel + botulinum toxin type A.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call